Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Oct. 22, 2018. Rachel Shelly.

Executive Summary

Ireland is successfully developing a medtech industry by making it a national priority. See what IDA Ireland's Rachel Shelly says attracts medtech companies to the country.

"Most companies, when they're thinking about Ireland, are looking at it in the context of access into Europe. [After Brexit] we're soon to be the only English-speaking country in the Eurozone, so for companies that looking to develop their international markets, Ireland is a great location to do that. Because we're a fully committed member of the EU, with proximity to Europe, the advantage of being an English-speaking [country] is not to be underestimated for international companies setting up there. It's great to be able to do business through English and with people that understand how American companies do business. That's been a big part of it." –Rachel Shelly, head of medical technologies, IDA Ireland

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel